<DOC>
	<DOCNO>NCT01103245</DOCNO>
	<brief_summary>The purpose study determine effect mineralocorticoid receptor ( MR ) antagonism renin inhibition glucose metabolism human .</brief_summary>
	<brief_title>Aldosterone Metabolic Syndrome</brief_title>
	<detailed_description>The purpose study determine effect mineralocorticoid receptor ( MR ) antagonism renin inhibition fast blood glucose glucose-stimulated insulin secretion human .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Metabolic Diseases</mesh_term>
	<mesh_term>Glucose Metabolism Disorders</mesh_term>
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Spironolactone</mesh_term>
	<mesh_term>Lactitol</mesh_term>
	<criteria>Subjects meet follow condition include study : 1 . Ambulatory subject , 18 70 year age , inclusive 2 . For female subject , follow condition must meet : 1. postmenopausal status least 1 year , 2. statuspost surgical sterilization , 3. childbearing potential , utilization adequate birth control willingness undergo urine betahcg test prior drug treatment every study day . 3 . A seated supine systolic blood pressure great 130/85 three separate measurement least 15 minute apart 4 . Metabolic Syndrome define presence &gt; 3 follow : 1 . Hypertension characterize Systolic Blood Pressure &gt; 140 mm Hg Diastolic Blood Pressure &gt; 90 mm Hg . 2 . Impaired Glucose Tolerance ( Fasting Plasma Glucose &gt; 100 mg/dL ) 3 . Increased triglyceride level &gt; 150mg/dL 4 . Decreased level HighDensity Lipoprotein ( HDL ) cholesterol 1 . For male , less 30 mg/dL 2 . For female , less 40 mg/dL 5 . Waist circumference 1 . For male , great 40 inch . 2 . For female , great 35 inch . Subjects present follow include study : 1 . Diabetes type 1 type 2 , fast glucose great 110 mg/dL use antidiabetic medication 2 . Use hormone replacement therapy 3 . Statin therapy 4 . Pregnancy 5 . Breastfeeding 6 . Cardiovascular disease prior myocardial infarction , presence angina pectoris , significant arrhythmia , congestive heart failure [ Left Ventricular ( LV ) hypertrophy acceptable ] , deep vein thrombosis , pulmonary embolism , second third degree heart block , mitral valve stenosis , aortic stenosis hypertrophic cardiomyopathy 7 . Treatment anticoagulants 8 . History serious neurologic disease cerebral hemorrhage , stroke , seizure , transient ischemic attack 9 . History presence immunological hematological disorder 10 . Diagnosis asthma require use inhale beta agonist &gt; 1 time per week 11 . Clinically significant gastrointestinal impairment could interfere drug absorption 12 . Impaired hepatic function [ aspartate amino transaminase ( AST ) and/or alanine amino transaminase ( ALT ) &gt; 1.5 x upper limit normal range ] 13 . Impaired renal function [ estimate glomerular filtration rate ( eGFR ) &lt; 60ml/min ] determine fourvariable Modification Diet Renal Disease ( MDRD ) equation , serum creatinine ( Scr ) express mg/dl age year : eGFR ( ml/min/1.73m2 ) =175 • Scr1.154 • age0.203 • ( 1.212 black ) • ( 0.742 female ) 14 . Hematocrit &lt; 35 % 15 . Any underlying acute disease require regular medication could possibly pose threat subject make implementation protocol interpretation study result difficult , arthritis treat nonsteroidal antiinflammatory drug 16 . Treatment chronic systemic glucocorticoid therapy ( 7 consecutive day 1 month ) 17 . Treatment lithium salt 18 . History alcohol drug abuse 19 . Treatment investigational drug 1 month precede study 20 . Mental condition render subject unable understand nature , scope possible consequence study 21 . Inability comply protocol , e.g. , uncooperative attitude , inability return followup visit , unlikelihood complete study 22 . Screening plasma potassium &lt; 3.2 mmol/L use chronic potassium supplement treatment hypokalemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2011</verification_date>
	<keyword>Glucose</keyword>
	<keyword>Insulin</keyword>
</DOC>